Targeting trisomic treatments: optimizing Dyrk1a inhibition to improve Down syndrome deficits

por Stringer, Megan, Goodlett, Charles R., Roper, Randall J.
Publicado 2017

Evaluation of the therapeutic potential of Epigallocatechin-3-gallate (EGCG) via oral gavage in young adult Down syndrome mice

por Goodlett, Charles R., Stringer, Megan, LaCombe, Jonathan, Patel, Roshni, Wallace, Joseph M., Roper, Randall J.
Publicado 2020